OUR MISSION

Napa Medical Research Foundation is a 501(c)(3) nonprofit organization committed to supporting research that provides valuable scientific and medical information, improves clinical care, leads to promising new treatments, promotes improved delivery of health care and otherwise benefits patients in the areas of prevention, treatment and rehabilitation of musculoskeletal conditions.

OUR VISION

To discover and advance new treatments in orthopedics, rehabilitation, neurology and sports medicine, and to share our findings with the broad medical community.

ADVANCE RESEARCH

SHARE KNOWLEDGE

IMPROVE TREATMENTS

GIVE & GAIN SUPPORT

RESEARCH HIGHLIGHT

What’s Ahead for the NEW Research Lab

With the dedicated assistance of biomedical laboratory consultant Ryan Dregalla, PhD, Dregalla Medical Technologies, the NMRF will greatly expand the scope and capacity of Dr Bodor’s research. Located in Suite C of the Wellness Center in Napa, the lab serves to complement current and future clinical studies, provide publication-grade data to support clinical findings, and further innovations in the diagnosis and treatment of orthopedic, musculoskeletal, and neurologic conditions and diseases.
In addition to the recently acquired fluorescent microscope, the fully functional lab facility houses a state-of-the-art flow cytometer, centrifuge, plate reader and incubator – all of which work in tandem to create sophisticated behavioral and compositional models, enable cell culture processing, and provide critical independence and autonomy for the research team. Each element can be optimized to specifically address and perform in keeping with the parameters and desired outcomes of each investigation.

Under the preliminary direction of Ryan Dregalla, the research team will focus their attention on two areas of study. The first study  focuses on characterizing the way that platelets and leukocytes in platelet rich plasma (PRP) interact with the tissues of the intervertebral disc to better understand how this therapy is used to optimize outcomes in patients with degenerative disc disease. This study will further investigate the role that stem cells derived from bone marrow influence these interactions with the intervertebral disc. The second study is focused on using a novel method to lyse platelets with an unprecedented efficiency and harness their therapeutic intracellular proteins without using techniques that otherwise damage these key factors. This product is intended for be for therapeutic use, and it may be patented and commercialized.

Read More about our initial research projects.

BECOME A STUDY PARTICIPANT

Enrolling now for Sever’s Disease Study

Since first described by Dr. James Sever in 1912, Sever’s Disease is a condition that typically affects children ages 8 – 14 and has been thought to be an inflammation of the growth plate. Characterized by pain the Achilles heel and tendon, treatments normally include immobilization of the foot and ankle through the use of cast-boots and restraint from physical activity.

Dr. Bodor formulated a new theory on its pathogenesis, and has developed a highly-successful treatment program. 40 children are, or have been, participants in the Sever’s Disease Study to-date, with 90% experiencing almost complete resolution of symptoms after just 2 weeks.

If you have a child, or know of one, diagnosed with Sever’s Disease – or suffering from a an undiagnosed chronic pain the heel or ankle, please contact Yvette Uribe, Research Assistant via email or at (707) 492-0313 to learn more about how to enroll in the Sever’s Disease Study.

HELP US TO ADVANCE NEW TREATMENTS TO ALLEVIATE PAIN, RESTORE FUNCTION, AND IMPROVE QUALITY OF LIFE.